Book a Meeting

Negative-Sense Single-Stranded RNA Viruses-focused Research-grade Drug Discovery Service

Creative Biolabs pioneer in providing top-notch, research-centered drug discovery services, specializing in the study of negative-sense single-stranded RNA ((-) ss-RNA) viruses. Our world-class facilities stand ready to facilitate the journey of scientists and researchers in uncovering and formulating therapeutic solutions targeted at these deleterious viruses.

Understanding Negative-Sense Single-Stranded RNA Viruses

Single-Stranded (-) RNA.

One of the distinguishing features of these viruses is the presence of a single-stranded, non-segmented, negative-sense RNA genome. Essentially, this means that the genome is oriented in reverse and requires translation into a positive-sense mRNA to be manipulated by the host cell.

Transcription.

The formation of mRNA in (-) ss-RNA viruses necessitates host cells' machinery. This is a multifaceted process that involves a variety of virus-encoded proteins.

Host range.

These viruses boast a wide host range, infecting entities ranging from plants and insects to humans, causing various diseases tailored to their specific hosts.

Bearing these attributes in mind, drug discovery and vaccine development initiatives count (-) ss-RNA viruses as a key focus. Our service aims to streamline these initiatives by offering a superior, research-driven platform for drug discovery.

Virus name Disease
Influenza Virus (Myxovirus) Influenza
Measles virus Measles
Mumps virus Mumps
Respiratory syncytial virus Respiratory infections
Rabies Virus (Rhabdoviridae) Rabies
Ebola virus (Filoviridae) Ebola virus disease
Marburg Virus (Filoviridae) Marburg virus disease
Lassa Virus (Arenaviridae) Lassa fever
Nipah Virus (Paramyxoviridae) Nipah virus infection
Crimean-Congo Hemorrhagic Fever Virus (Bunyaviridae) Crimean-Congo Hemorrhagic fever
Hendra Virus (Paramyxoviridae) Hendra virus infection

Tab.1 Examples of (-) ss-RNA viruses as well as their associated diseases.

Fig. 1 (-) ss-RNA viruses virion structures. (Šantak, et al., 2022)Fig. 1 The virion structures peculiar to the (-) ss-RNA viruses.1

Service Overview

Our Services Include:

  • In-depth research and analysis. Our team is keen to conduct thorough research, focusing on the replication, genetic variation, and infection processes of (-) ss-RNA viruses.
  • Drug prototyping. Based on our research findings, we offer guidance in the development of drug prototypes tailored to effectively target specific (-) ss-RNA viruses.
  • Pre-clinical trial support. We provide logistical assistance in streamlining efficacy and safety trials for prospective drug candidates.
  • Customized research. We provide tailored research services catering to our client's unique requirements.

Advantages of Opting for Our Services

  • Top-Tier expertise. Our team consists of seasoned virologists, biomedical researchers, and drug discovery specialists.
  • Data integrity. We uphold strict standards of data management while ensuring complete adherence to research ethics.
  • Confidentiality. We honor the proprietary information of our clients by guaranteeing the utmost confidentiality of all research data and findings.

At Creative Biolabs, we orchestrate a dynamic platform that stimulates advanced research on (-) ss-RNA viruses. Our mission is to assist in the discovery of potential drugs that can combat and prevent diseases caused by these viruses. For further inquiries, please contact our team.

Reference:

  1. Šantak, Maja, and Zrinka Matić. "The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses—Not Just Another Brick in the Viral Nucleocapsid." Viruses 14.3 (2022): 521.
For Research Use Only. We do not provide direct services or products for patients.
Related Services:
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.

Contact Us
Contact Us
  • (USA)
    (UK)
    (Germany)
  • Global Locations